| scholarly article | Q13442814 |
| P50 | author | Gerd Geerling | Q15280969 |
| Christophe Baudouin | Q37616711 | ||
| P2093 | author name string | Jay S Pepose | |
| Gary N Foulks | |||
| Michael A Lemp | |||
| Anthony J Bron | |||
| Kelly K Nichols | |||
| Alan Tomlinson | |||
| P433 | issue | 2 Suppl | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | S1-31 | |
| P577 | publication date | 2014-02-13 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | Rethinking dry eye disease: a perspective on clinical implications | |
| P478 | volume | 12 |
| Q59104204 | A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments, and Future Challenges |
| Q33837188 | A novel TRPM8 agonist relieves dry eye discomfort |
| Q34474379 | A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome |
| Q34087380 | Age-related changes of the ocular surface: a hospital setting-based retrospective study |
| Q89599597 | Associations between the menstrual cycle, lifestyle factors and clinical assessment of the ocular surface: a prospective observational study |
| Q35762942 | Changes of Ocular Surface and the Inflammatory Response in a Rabbit Model of Short-Term Exposure Keratopathy |
| Q39151688 | Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature |
| Q60922643 | Clinically Relevant Immune-Cellular Metrics of Inflammation in Meibomian Gland Dysfunction |
| Q55250864 | Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis. |
| Q39987388 | Comparing self-reported optometric dry eye clinical practices in Australia and the United Kingdom: is there scope for practice improvement? |
| Q48236970 | Controlled Adverse Environment Chambers in Dry Eye Research. |
| Q38235721 | Current Approach to Dry Eye Disease. |
| Q92465209 | Defining the needs and preferences of patients with dry eye disease |
| Q36009304 | Dry Eye Disease Patients with Xerostomia Report Higher Symptom Load and Have Poorer Meibum Expressibility. |
| Q64060184 | Dry Eye Disease: Consideration for Women's Health |
| Q98611558 | Dry eye in rheumatoid arthritis patients under TNF-inhibitors: conjunctival goblet cell as an early ocular biomarker |
| Q58795856 | Dry eye symptoms and impact on vision-related function across International Task Force guidelines severity levels in the United States |
| Q35190697 | Dynamics and function of the tear film in relation to the blink cycle |
| Q57286179 | Dynasore protects the ocular surface against damaging stress |
| Q36252489 | Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment |
| Q45021365 | Dyslipidemia and its association with meibomian gland dysfunction |
| Q37485819 | Effect of trapping vascular endothelial growth factor-A in a murine model of dry eye with inflammatory neovascularization |
| Q35732401 | Effects of Dry Eye Therapies on Environmentally Induced Ocular Surface Disease |
| Q36137428 | Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial |
| Q37500497 | Etiology, diagnosis, management and outcomes of epiphora referrals to an oculoplastic practice |
| Q35177377 | Evidence for TRPA1 involvement in central neural mechanisms in a rat model of dry eye. |
| Q38905054 | External eye symptoms in indoor environments |
| Q33727595 | Fibroblast Growth Factor Receptor 2 (FGFR2) Is Required for Meibomian Gland Homeostasis in the Adult Mouse |
| Q50534206 | Hydroxypropyl methylcellulose 2% for dry eye prevention during phacoemulsification in senile and diabetic patients. |
| Q49924138 | Impact of Smoking on the Ocular Surface, Tear Function, and Tear Osmolarity. |
| Q92669446 | Improvement of conjunctival cytological grade and tear production in Ankylosing Spondylitis patients under TNF inhibitors: a long-term follow-up |
| Q36093656 | In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells |
| Q90010378 | Inflammatory Ocular Diseases and Sphingolipid Signaling |
| Q28364856 | Interobserver variability of an open-source software for tear meniscus height measurement |
| Q58125164 | Lacrimal Gland Denervation Alters Tear Protein Composition and Impairs Ipsilateral Eye Closures and Corneal Nociception |
| Q59794055 | Lifitegrast add-on treatment for dupilumab-induced ocular surface disease (DIOSD): A novel case report |
| Q47637582 | Meibomian Gland Disease: The Role of Gland Dysfunction in Dry Eye Disease |
| Q38697707 | Meibomian glands, meibum, and meibogenesis |
| Q52608828 | Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye. |
| Q26773997 | Pollutant exposures and health symptoms in aircrew and office workers: Is there a link? |
| Q47547213 | Prevalence and Risk Factors of self-reported dry eye in Brazil using a short symptom questionnaire |
| Q28073073 | Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis |
| Q58781979 | Quality of life measures and health utility values among dry eye subgroups |
| Q33739984 | Randomized comparison of in vivo performance of two point-of-care tear film osmometers |
| Q50034049 | Relation Between Dietary Essential Fatty Acid Intake and Dry Eye Disease and Meibomian Gland Dysfunction in Postmenopausal Women. |
| Q90341490 | Role of Bioactive Sphingolipids in Inflammation and Eye Diseases |
| Q90481097 | TRPV1 and TRPM8 Channels and Nocifensive Behavior in a Rat Model for Dry Eye |
| Q90523884 | Tear eicosanoids in healthy people and ocular surface disease |
| Q50665912 | The Conjunctiva-Associated Lymphoid Tissue in Chronic Ocular Surface Diseases. |
| Q33800932 | The Diagnosis and Treatment of Sjögren's Syndrome. |
| Q33756582 | The Growing Need for Validated Biomarkers and Endpoints for Dry Eye Clinical Research |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q41352146 | The role of lipids in corneal diseases and dystrophies: a systematic review |
| Q37210882 | Understanding the true burden of dry eye disease |
| Q47424328 | Update in Current Diagnostics and Therapeutics of Dry Eye Disease. |
| Q90173270 | [Intense pulsed light (IPL) as a therapeutic option for Meibomian gland dysfunction] |
Search more.